​
​

Impel Pharmaceuticals Ownership | Who Owns Impel Pharmaceuticals?

OverviewChart

Impel Pharmaceuticals Ownership Summary

Impel Pharmaceuticals is owned by 11.63% institutional investors, and 88.37% retail investors. BlackRock Advantage SMID Cap V.I. Fd I is the top mutual fund, with 0.01% of its assets in Impel Pharmaceuticals shares.

IMPL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockImpel Pharmaceuticals11.63%-88.37%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
BlackRock Advantage SMID Cap V.I. Fd I2.62K0.01%-
BlackRock Extended Mkt Composite347.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 18, 2023Vivo Capital VIII, LLC-Sell$22.99K
Dec 19, 2023Vivo Capital VIII, LLC-Sell$16.69K
Dec 15, 2023Vivo Capital VIII, LLC-Sell$3.50K
Dec 18, 2023Vivo Capital VIII, LLC-Sell$3.16K
Dec 15, 2023Vivo Capital VIII, LLC-Sell$25.50K

Insider Transactions Trends

DateBuySell
2023 Q4-6
2023 Q2--
2023 Q1--
2022 Q4--
2022 Q2--

IMPL Ownership FAQ

Who Owns Impel Pharmaceuticals?

Impel Pharmaceuticals shareholders are primarily institutional investors at 11.63%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Impel Pharmaceuticals's industry, Biotech Stocks , is 45.35%, which Impel Pharmaceuticals falls below.

Does Blackrock own Impel Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Impel Pharmaceuticals.

Who is the top mutual fund holder of Impel Pharmaceuticals shares?

BlackRock Advantage SMID Cap V.I. Fd I is the top mutual fund holder of Impel Pharmaceuticals shares, with 0.01% of its total shares outstanding invested in 2.62K Impel Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools